Literature DB >> 2692868

Comparative analysis of ELISAs employing repetitive peptides to detect antibodies to Plasmodium falciparum sporozoites.

G Del Giudice, A Douglas, J P Verhave, R A Wirtz, F Zavala.   

Abstract

In the last few years, a number of different recombinant and synthetic peptides consisting of the repetitive sequence of the Plasmodium falciparum circumsporozoite protein (NANP)n have been produced and used to develop immunoassays for the detection of antibodies against P. falciparum sporozoites in human sera. A comparative study of three enzyme-linked immunosorbent assays (ELISAs) that employed different (NANP)n peptides (the synthetic peptides (NANP)3 and (NANP)40 as well as the recombinant peptides R32tet32 and R32LR) was carried out using serum samples from individuals who were living in different malaria-endemic areas. The results obtained for these peptide-based ELISAs were compared with those obtained for an immunofluorescence assay (IFA) that used glutaraldehyde-fixed sporozoites. All the methods tested exhibited 100% specificity on sera from persons not exposed to malaria, good reproducibility (coefficients of variation ranged from 3% to 15% for peptide-based ELISAs), and good sensitivity. Reproducibility and sensitivity were lower for the IFA than for the peptide-based ELISAs, perhaps because of the subjective element in the interpretation of the results which is inherent in the IFA method. ELISAs based on peptides that contain a higher number of (NANP) repeats, i.e., (NANP)40 and R32tet32 or R32LR, gave results which correlated better with each other than with those obtained with the ELISA that employed a shorter (NANP)3 peptide. (NANP)n-based ELISAs are relatively simple and inexpensive methods for the detection of anti-P. falciparum sporozoite antibodies and can readily be used in epidemiological research in the field. These assays could contribute to a better understanding of the natural history of the host-parasite relationship in malaria research.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692868      PMCID: PMC2491287     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  16 in total

1.  Detection of antibodies in human sera to the repeating epitope of the circumsporozoite protein of Plasmodium falciparum using the synthetic peptide (NANP)3 in an enzyme-linked immunosorbent assay (ELISA).

Authors:  G H Campbell; A D Brandling-Bennett; J M Roberts; F H Collins; D C Kaseje; A M Barber; A Turner
Journal:  Am J Trop Med Hyg       Date:  1987-07       Impact factor: 2.345

2.  Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development.

Authors:  V F de la Cruz; A A Lal; T F McCutchan
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

3.  Strain variation in the circumsporozoite protein gene of Plasmodium falciparum.

Authors:  M J Lockyer; R T Schwarz
Journal:  Mol Biochem Parasitol       Date:  1987-01-02       Impact factor: 1.759

4.  Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.

Authors:  W R Ballou; S L Hoffman; J A Sherwood; M R Hollingdale; F A Neva; W T Hockmeyer; D M Gordon; I Schneider; R A Wirtz; J F Young
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

5.  Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites.

Authors:  F Zavala; J P Tam; A Masuda
Journal:  J Immunol Methods       Date:  1986-10-23       Impact factor: 2.303

6.  Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.

Authors:  S L Hoffman; R Wistar; W R Ballou; M R Hollingdale; R A Wirtz; I Schneider; H A Marwoto; W T Hockmeyer
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

7.  Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.

Authors:  S L Hoffman; C N Oster; C V Plowe; G R Woollett; J C Beier; J D Chulay; R A Wirtz; M R Hollingdale; M Mugambi
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

8.  Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Authors:  G Del Giudice; H D Engers; C Tougne; S S Biro; N Weiss; A S Verdini; A Pessi; A A Degremont; T A Freyvogel; P H Lambert
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

9.  Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32).

Authors:  H K Webster; E F Boudreau; L W Pang; B Permpanich; P Sookto; R A Wirtz
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

10.  Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

Authors:  J B Dame; J L Williams; T F McCutchan; J L Weber; R A Wirtz; W T Hockmeyer; W L Maloy; J D Haynes; I Schneider; D Roberts
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

View more
  4 in total

Review 1.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines.

Authors:  Stefan Kostense; Bregje Mommaas; Jenny Hendriks; Mariëlle Verhoeven; Mariska Ter Haak; Felicia Tirion; Edison Wiesken; Maria Grazia Pau; Katarina Radosevic; Jaap Goudsmit
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

3.  Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance.

Authors:  D Gozal; C Hengy; G Fadat
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

4.  Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.

Authors:  Frederic Clement; Vincent Dewar; Eva Van Braeckel; Isabelle Desombere; Marianne Dewerchin; Christine Swysen; Marie-Ange Demoitié; Erik Jongert; Joe Cohen; Geert Leroux-Roels; Pierre Cambron
Journal:  Malar J       Date:  2012-11-22       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.